Francis M. Barnieh
Bradford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Aminopeptidase N (CD13): Bridging physiology, pathology and therapeutic potential.
Journal: Advances in clinical chemistry
Published: October 01, 2025
Decoding the adaptive survival mechanisms of breast cancer dormancy.
Journal: Oncogene
Published: April 09, 2025
Hypoxia-Responsive Prodrug of ATR Inhibitor, AZD6738, Selectively Eradicates Treatment-Resistant Cancer Cells.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 11, 2024
The DNA repair kinase ATM regulates CD13 expression and cell migration.
Journal: Frontiers in cell and developmental biology
Published: December 20, 2023
Targeted delivery of a colchicine analogue provides synergy with ATR inhibition in cancer cells.
Journal: Biochemical pharmacology
Published: March 30, 2022
Is tumour-expressed aminopeptidase N (APN/CD13) structurally and functionally unique?
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: September 19, 2021
Probing cytochrome P450 (CYP) bioactivation with chloromethylindoline bioprecursors derived from the duocarmycin family of compounds.
Journal: Bioorganic & medicinal chemistry
Published: February 20, 2021
Progress towards a clinically-successful ATR inhibitor for cancer therapy.
Journal: Current research in pharmacology and drug discovery
Published: November 30, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026